- Home
- IMNM vs NBN Comparison
IMNM vs NBN Comparison
Compare IMNM & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- NBN
- Stock Information
- Founded
- IMNM 2006
- NBN 1872
- Country
- IMNM United States
- NBN United States
- Employees
- IMNM N/A
- NBN N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- NBN Major Banks
- Sector
- IMNM Health Care
- NBN Finance
- Exchange
- IMNM Nasdaq
- NBN Nasdaq
- Market Cap
- IMNM 747.7M
- NBN 697.0M
- IPO Year
- IMNM 2020
- NBN N/A
- Fundamental
- Price
- IMNM $9.91
- NBN $99.48
- Analyst Decision
- IMNM Strong Buy
- NBN Buy
- Analyst Count
- IMNM 5
- NBN 1
- Target Price
- IMNM $28.60
- NBN $80.00
- AVG Volume (30 Days)
- IMNM 695.8K
- NBN 77.6K
- Earning Date
- IMNM 11-13-2024
- NBN 10-29-2024
- Dividend Yield
- IMNM N/A
- NBN 0.04%
- EPS Growth
- IMNM N/A
- NBN 12.22
- EPS
- IMNM N/A
- NBN 7.69
- Revenue
- IMNM $10,129,000.00
- NBN $157,668,000.00
- Revenue This Year
- IMNM N/A
- NBN N/A
- Revenue Next Year
- IMNM N/A
- NBN N/A
- P/E Ratio
- IMNM N/A
- NBN $12.93
- Revenue Growth
- IMNM N/A
- NBN 16.87
- 52 Week Low
- IMNM $6.93
- NBN $49.07
- 52 Week High
- IMNM $30.96
- NBN $105.44
- Technical
- Relative Strength Index (RSI)
- IMNM 30.69
- NBN 69.03
- Support Level
- IMNM $12.46
- NBN $100.68
- Resistance Level
- IMNM $13.52
- NBN $105.00
- Average True Range (ATR)
- IMNM 0.85
- NBN 3.61
- MACD
- IMNM -0.15
- NBN 0.29
- Stochastic Oscillator
- IMNM 6.71
- NBN 68.94
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About NBN Northeast Bank
Northeast Bank provides banking and financial services to individual and corporate customers in the US. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived primarily from interest and dividends from the bank.